Media
https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otc-etbi/
March 25, 2019
Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)
Read moreEastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply
March 19, 2019
Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse
Read moreEastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships
January 30, 2019
EastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre
Read moreEastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019
December 19, 2018
Eastgate Biotech Corp.appointed key consultants Saul A. Mashaal, PhmB, MBA and Munaf Ali, PhD to assist in regulatory matters and manufacturing of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients.
Read moreEastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives
November 19, 2018
EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives
Read moreCORRECTED LINK: CEO Anna Gluskin's interview with Uptick Newswire on 17 October 2018
October 22, 2018
Eastgate Biotech Corp. CEO Anna Gluskin's interview with Uptick Newswire on October 17, 2018
Read moreCEO Anna Gluskin, Interview with Uptick Network on October 17, 2018
October 22, 2018
Anna Gluskin's interview with Uptick Network on October 17, 2018
Read moreCEO Anna Gluskin's interview-Uptick network 17Oct2018
October 22, 2018
Anna Gluskin, CEO, Eastgate Biotech Corp. Interview on Uptick Network on 17Oct.2018
Read moreEastGate Biotech Signs Definitive Investment
August 27, 2018
EastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution Non-Dilutive Investment and Product License includes licensing fee and development costs
Read moreEastGate Biotech Provides Update on investment from Genluiching Mining Corporation
July 24, 2018
EastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement.
Read more